SER-109
Seres Therapeutics
['$mcrb', 'seres therap']
$mcrb seres therapeutics and nestl health science present results from ecospor iv phase 3 study of vowst , a microbiota-based oral therapeutic for prevention of recurrence of c. difficile infection, at the digestive disease week (ddw) annual meeting 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6